BRAF gene mutation leads to different therapeutic responses in melanoma and colorectal cancer

A review article led by researchers from the B·ARGO group at the Germans Trias i Pujol Research Institute (IGTP) and from the Medical Oncology Department of the Catalan Institute of Oncology (ICO) in Badalona provides a comparative analysis of…

Continue Reading

News Source: medicalxpress.com